Literature DB >> 20425157

Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Markus P Schlaich1, Henry Krum, Paul A Sobotka.   

Abstract

The sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, as elevated sympathetic nerve activity initiates and sustains the elevation of blood pressure. Increased sympathetic outflow to the heart, resulting in increased cardiac output and neurally mediated vasoconstriction of peripheral blood vessels, is an obvious example of a neural pathophysiologic pathway leading to elevated blood pressure. The consequences of increased sympathetic outflow to the kidneys, perhaps most important in this context, are sodium and water retention, increased renin release, and alterations of renal blood flow-effects that contribute substantially to both acute and long-term blood pressure elevations. Accordingly, renal sympathetic nerve ablation appears to be a logical therapeutic approach for the treatment of hypertension. Recent reports on a novel catheter-based renal nerve ablation procedure reviewed in this article are promising.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425157     DOI: 10.1007/s11906-009-0078-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  A limited renal injury may cause a permanent form of neurogenic hypertension.

Authors:  S Ye; M Gamburd; P Mozayeni; M Koss; V M Campese
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

2.  Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.

Authors:  G Ligtenberg; P J Blankestijn; P L Oey; I H Klein; L T Dijkhorst-Oei; F Boomsma; G H Wieneke; A C van Huffelen; H A Koomans
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Preeclampsia -- a state of sympathetic overactivity.

Authors:  H P Schobel; T Fischer; K Heuszer; H Geiger; R E Schmieder
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

5.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

6.  Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.

Authors:  Shaohua Ye; Huiqin Zhong; Vijay Yanamadala; Vito M Campese
Journal:  Am J Hypertens       Date:  2002-08       Impact factor: 2.689

Review 7.  Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions.

Authors:  L U Mailloux; W E Haley
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 8.  Noradrenaline release and the pathophysiology of primary human hypertension.

Authors:  M Esler; G Jennings; G Lambert
Journal:  Am J Hypertens       Date:  1989-03       Impact factor: 2.689

9.  Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

Authors:  Markus P Schlaich; Elisabeth Lambert; David M Kaye; Zygmunt Krozowski; Duncan J Campbell; Gavin Lambert; Jacqui Hastings; Anuradha Aggarwal; Murray D Esler
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

Review 10.  Causes and consequences of increased sympathetic activity in renal disease.

Authors:  Jaap A Joles; Hein A Koomans
Journal:  Hypertension       Date:  2004-02-23       Impact factor: 10.190

View more
  15 in total

Review 1.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

2.  Renal Sympathetic Denervation for Treatment of Hypertension.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02-01

Review 3.  The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

Authors:  Revathy Carnagarin; Vance Matthews; Maria T K Zaldivia; Karlheinz Peter; Markus P Schlaich
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

4.  Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results.

Authors:  Alice Bonanni; Francesco Pasetti; Gian Marco Ghiggeri; Carlo Gandolfo
Journal:  BMJ Case Rep       Date:  2015-03-10

5.  Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.

Authors:  Rainer H Straub; Boris Ehrenstein; Florian Günther; Luise Rauch; Nadezhda Trendafilova; Dario Boschiero; Joachim Grifka; Martin Fleck
Journal:  Clin Rheumatol       Date:  2016-04-26       Impact factor: 2.980

6.  Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.

Authors:  Su Young Han; Emily Gray; Gillian Hughes; Colin H Brown; Daryl O Schwenke
Journal:  Pflugers Arch       Date:  2013-08-25       Impact factor: 3.657

7.  Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience.

Authors:  M Voskuil; W L Verloop; P J Blankestijn; P Agostoni; P R Stella; P A Doevendans
Journal:  Neth Heart J       Date:  2011-08       Impact factor: 2.380

Review 8.  Renal sympathetic denervation for treatment of resistant hypertension: a systematic review.

Authors:  Priyanka Gosain; Pranav S Garimella; Peter D Hart; Rajender Agarwal
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-26       Impact factor: 3.738

9.  Increased extracellular water measured by bioimpedance analysis and increased serum levels of atrial natriuretic peptide in polymyalgia rheumatica patients : Signs of volume overload.

Authors:  F Günther; B Ehrenstein; W Hartung; D Boschiero; M Fleck; R H Straub
Journal:  Z Rheumatol       Date:  2021-03       Impact factor: 1.372

10.  Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience.

Authors:  Mehrdad Honarvar; Afshin Amirpour; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.